Cite

HARVARD Citation

    Swisher, E. et al. (n.d.). Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial. Lancet oncology. 18 (1), pp. 75-87. [Online]. 
  
Back to record